Justin Adam Smith serves as Executive at Journey Medical Corp, where they oversee executive responsibilities. Since joining the company, Justin Adam Smith has executed 8 insider transactions totaling $202.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 5, 2025 involved receiving (via award) 20,000 shares valued at $0.
Justin Adam Smith currently holds 171,618 shares of Journey Medical Corp (DERM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Justin Adam Smith has been a net buyer of DERM stock. They have purchased $202.4K and sold $0 worth of shares.
Justin Adam Smith's most recent insider trade was on Aug 5, 2025, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 8, 2024 | DERM | $0 | Award | 9,728 | $N/A | Discretionary |
| Mar 22, 2024 | DERM | $104.1K | Purchase | 30,000 | $3.47 | Discretionary |
| Oct 13, 2023 | DERM | $98.3K | Purchase | 33,000 | $2.98 | Discretionary |
| Jul 21, 2023 | DERM | $0 | Award | 27,472 | $N/A | Discretionary |
| Jul 21, 2022 | DERM | $0 | Award | 14,245 | $N/A | Discretionary |
| Jan 14, 2022 | DERM | $0 | Award | 30,000 | $N/A | Discretionary |